Biomaterials, situated at the nexus of nanotechnology and biomedical engineering, have revolutionized modern healthcare. Engineered at the nanoscale, they exhibit extraordinary bioactivity, profoundly impacting drug delivery, tissue engineering, and immunotherapy. These materials serve as adept carriers in drug delivery, ensuring precise administration and minimizing side effects. In tissue engineering, biomaterials provide scaffolds that emulate the native extracellular matrix, guiding tissue regeneration. The integration of nanotechnology enhances their interactions with biological systems, enabling finely-tuned drug delivery and immune modulation. This convergence is particularly potent in immunotherapy, where biomaterials bolster the body's immune response against diseases. In this dynamic field, biomaterials, synergizing with nanotechnology, hold immense potential for targeted, personalized healthcare solutions.
This Research Topic aims to address the pressing challenges and opportunities at the forefront of biomaterials research, particularly in the context of drug delivery, tissue engineering, and immunotherapy. Recent advances in nanotechnology have ushered in a new era of biomaterials engineering, offering unprecedented control and precision in therapeutic interventions. One of the key challenges is maximizing the therapeutic efficacy of drug delivery systems while minimizing adverse effects. This necessitates the development of biomaterial-based carriers that can navigate physiological barriers and release therapeutics with spatiotemporal precision. Recent breakthroughs in targeted delivery strategies, leveraging the unique properties of nanomaterials, have shown promising results in pre-clinical and clinical settings. Furthermore, in tissue engineering, achieving functional tissue regeneration remains a paramount goal. Biomaterial scaffolds, especially those enhanced by nanotechnology, hold immense potential in guiding cellular behavior and orchestrating tissue growth. Recent strides in bioactive materials design and 3D printing techniques have propelled the field forward, allowing for the creation of intricate, biomimetic scaffolds.
This Research Topic focuses on recent advances in bioactive and biomimetic materials. We welcome Original Research Articles, Reviews, and Mini-Reviews. Specific themes include:
• Bioactive inorganic materials
• Bioactive organic materials
• Bioactive composites
• Biomimetic materials
• Bioactive materials for cancer theranostics/immunotherapy
• Nanomaterials for biomedical applications
• Biomaterials for tissue engineering
• Biomaterials for inflammation
• Biomaterials for drug delivery
• Safety and degradability of Bioactive materials
Biomaterials, situated at the nexus of nanotechnology and biomedical engineering, have revolutionized modern healthcare. Engineered at the nanoscale, they exhibit extraordinary bioactivity, profoundly impacting drug delivery, tissue engineering, and immunotherapy. These materials serve as adept carriers in drug delivery, ensuring precise administration and minimizing side effects. In tissue engineering, biomaterials provide scaffolds that emulate the native extracellular matrix, guiding tissue regeneration. The integration of nanotechnology enhances their interactions with biological systems, enabling finely-tuned drug delivery and immune modulation. This convergence is particularly potent in immunotherapy, where biomaterials bolster the body's immune response against diseases. In this dynamic field, biomaterials, synergizing with nanotechnology, hold immense potential for targeted, personalized healthcare solutions.
This Research Topic aims to address the pressing challenges and opportunities at the forefront of biomaterials research, particularly in the context of drug delivery, tissue engineering, and immunotherapy. Recent advances in nanotechnology have ushered in a new era of biomaterials engineering, offering unprecedented control and precision in therapeutic interventions. One of the key challenges is maximizing the therapeutic efficacy of drug delivery systems while minimizing adverse effects. This necessitates the development of biomaterial-based carriers that can navigate physiological barriers and release therapeutics with spatiotemporal precision. Recent breakthroughs in targeted delivery strategies, leveraging the unique properties of nanomaterials, have shown promising results in pre-clinical and clinical settings. Furthermore, in tissue engineering, achieving functional tissue regeneration remains a paramount goal. Biomaterial scaffolds, especially those enhanced by nanotechnology, hold immense potential in guiding cellular behavior and orchestrating tissue growth. Recent strides in bioactive materials design and 3D printing techniques have propelled the field forward, allowing for the creation of intricate, biomimetic scaffolds.
This Research Topic focuses on recent advances in bioactive and biomimetic materials. We welcome Original Research Articles, Reviews, and Mini-Reviews. Specific themes include:
• Bioactive inorganic materials
• Bioactive organic materials
• Bioactive composites
• Biomimetic materials
• Bioactive materials for cancer theranostics/immunotherapy
• Nanomaterials for biomedical applications
• Biomaterials for tissue engineering
• Biomaterials for inflammation
• Biomaterials for drug delivery
• Safety and degradability of Bioactive materials
